These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13689296)

  • 1. Interaction of nicotinamide with reserpine and chlorpromazine. II. Some effects on the central nervous system of the mouse.
    BURTON RM; SALVADOR RA; GOLDIN A; HUMPHREYS SR
    Arch Int Pharmacodyn Ther; 1960 Nov; 128():253-9. PubMed ID: 13689296
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of nicotinamide with reserpine and chlorpromazine. III. Some effects on the diphosphopyridine nucleotide content in liver.
    BURTON RM; KAPLAN NO; GOLDIN A; LEITENBERG M; HUMPHREYS SR
    Arch Int Pharmacodyn Ther; 1960 Nov; 128():260-75. PubMed ID: 13689295
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of an antimetabolite, 6-amino-nicotinamide, on the central nervous system.
    WOLF A; COWEN D; GELLER LM
    Trans Am Neurol Assoc; 1959; 84():140-5. PubMed ID: 13845622
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of chlorpromazine and reserpine on the central actions of morphine in the cat.
    QUINN G; BRODIE BB
    Med Exp Int J Exp Med; 1961; 4():349-55. PubMed ID: 14489501
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the central actions of nicotinamide].
    BUCHEL L; LEVY J
    Therapie; 1962; 17():277-86. PubMed ID: 13874253
    [No Abstract]   [Full Text] [Related]  

  • 6. Reserpine action on the central nervous system of the cat.
    HAMEL EG; KAELBER WW
    Am J Physiol; 1961 Feb; 200():195-200. PubMed ID: 13710985
    [No Abstract]   [Full Text] [Related]  

  • 7. 6-Aminonicotinamide, a central nervous system depressant.
    REDETZKI HM; ALVAREZ-O'BOURKE F
    J Pharmacol Exp Ther; 1962 Aug; 137():173-8. PubMed ID: 14490930
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathological changes in the central nervous system produced by 6-aminonicotinamide.
    WOLF A; COWEN D
    Bull N Y Acad Med; 1959 Dec; 35(12):814-7. PubMed ID: 13845623
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peripheral actions and central actions of reserpine from the pharmacological and therapeutic viewpoint].
    VALDECASAS FG; SALVA JA
    Arch Med Exp; 1960; 23():363-9. PubMed ID: 13779690
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modification of the tranquilizing effect of reserpine and an analysis of its central effect].
    KNOLL J; KNOLL B
    Kiserl Orvostud; 1961 Oct; 13():457-67. PubMed ID: 14457306
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of the chronic administration of reserpine on the genital function of the male rat. Changes in sex behavior, the genital tract and central nervous system changes].
    SOULAIRAC A; SOULAIRAC ML
    Ann Endocrinol (Paris); 1962; 23():281-92. PubMed ID: 13915397
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reversibility of changes caused by prolonged use of therapeutic and subtoxic doses of reserpine (experimental-morphological study)].
    MATVEEV VF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1961; 61():1871-6. PubMed ID: 14471471
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the subject of the permeability behavior of the CNS under the effect of reserpine and orphenadrine].
    LIEBALDT G
    Med Esp; 1960; 2():377-80. PubMed ID: 13761977
    [No Abstract]   [Full Text] [Related]  

  • 14. Discussion: Pavlovian Conference on Higher Nervous Activity. III. Deviance and drugs.
    KILLAM KF
    Ann N Y Acad Sci; 1961 Jul; 92():1031-3. PubMed ID: 13755949
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of resperine on the functional state of the higher nervous centers in patients with hypertension].
    KARAKULINA TT
    Tr Leningr Sanitarnogig Med Inst; 1959; 48():192-6. PubMed ID: 13853253
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in the higher nervous activity and tone of the cerebral vessels in schizophrenics.
    STARITSYN AS; MOSCOVCHENKO KP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1961; 11():248-55. PubMed ID: 14039486
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of therapeutic and subtoxic doses of serpasil on the brain and internal organs of animals in chronic experimental conditions].
    MATVEEV VF
    Arkh Patol; 1961; 23(12)():28-33. PubMed ID: 14471472
    [No Abstract]   [Full Text] [Related]  

  • 18. THE EFFECT OF RESERPINE, CHLORPROMAZINE AND HALOPERIDOL ON THE MONOAMINES IN CENTRAL NERVOUS SYSTEM.
    Roos BE
    Acta Psychiatr Scand; 1964; 39(S180):421-2. PubMed ID: 14345228
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of reserpine and its derivatives on release of biogenic amines. Comparative study of the activity of reserpine and diethylaminoethyl-1-reserpine as bitartrates (author's transl)].
    Cholet R
    Arzneimittelforschung; 1977; 27(5):1004-5. PubMed ID: 577861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nicotinic acid and its amide on higher nervous activity].
    NIKOLOV NA
    Vopr Pitan; 1962; 21():64-8. PubMed ID: 14479834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.